Thermo Fisher Scientific (TMO) Tops Q2 EPS by 1c; Nudges Up FY11 Outlook
Tweet
Share
E-mailGet Alerts TMO Hot Sheet
Price: $588.29 -1.28%
Financial Fact:
Other Expense, Net: -113.2M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Other Expense, Net: -113.2M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Thermo Fisher Scientific (NYSE: TMO) reported Q2 EPS of $0.99, $0.01 better than the analyst estimate of $0.98. Revenue for the quarter came in at $2.9 billion versus the consensus estimate of $2.84 billion.
Thermo Fisher Scientific sees FY2011 EPS of $4.08-$4.18, versus prior guidance of $4.05-$4.15 and the consensus of $4.13. Thermo Fisher Scientific sees FY2011 revenue of $11.60-$11.70 billion, versus prior guidance of $11.52-$11.62 billion and the consensus of $11.59 billion.
Thermo Fisher Scientific sees FY2011 EPS of $4.08-$4.18, versus prior guidance of $4.05-$4.15 and the consensus of $4.13. Thermo Fisher Scientific sees FY2011 revenue of $11.60-$11.70 billion, versus prior guidance of $11.52-$11.62 billion and the consensus of $11.59 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
- Sandisk targets mid-to-high teens revenue growth through FY2030
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
